Contraindications to Warfarin
Bleeding diathesis
Previous GI bleeding
Intracranial hemorrhage/aneurysm/retinopathy
Severe hypertension
Bacterial endocarditis
Alcoholism
Unsupervised dementia
Frequent falls
First trimester of pregnancy
Other Risk Factors for Adverse Events on Warfarin
Elderly
Polypharmacy
Renal impairment
Hepatic impairment
Pregnancy
Recent surgery/trauma/heart failure/thyrotoxicosis
Advice on Warfarin
Nature of Warfarin
Warfarin is an oral anticoagulant that thins the blood to prevent clot formation in the legs and other parts of the body.
Benefits
Recommended for the prevention of recurrent DVT due to the risk of potentially life-threatening pulmonary embolism (PE).
Risks
Bleeding
Major bleeding < 2% per year.
INR is a major determinant, especially if > 3.
Bleeding is most likely in the first 3 months of therapy.
Risk in Pregnancy (Teratogenicity)
Recognized teratogen (Category D) – crosses placenta.
Contraindicated in pregnancy.
First trimester: Fetal warfarin syndrome (FWS)/warfarin embryopathy (bone stippling & nasal hypoplasia).
Third trimester: Perinatal fetal or placental hemorrhage.
Infrequent Idiosyncratic Reactions (Type B)
Rashes
Purple discoloration of toes
Skin necrosis
Fever
Cholesterol embolism
Allergic reactions
Alopecia
Nausea & vomiting
Hepatic dysfunction
Diarrhea
Interactions
Warfarin is metabolized by liver enzymes (cytochrome P450). Many medications and herbal preparations can affect its absorption, binding, and metabolism.
Drugs that Inhibit Cytochrome P450 Enzymes (Increased Effect)
Antibiotics: erythromycin, ciprofloxacin, co-trimoxazole, metronidazole, fluconazole.
Drugs that Induce Hepatic Enzymes (Reduced Effect)
Antibiotics: rifampicin.
Antiepileptics: carbamazepine, phenytoin.
St. John’s Wort
Alcohol
Antiplatelet Drugs (Additive Effect – Avoid)
Aspirin
Clopidogrel
Dipyridamole
Monitoring
Controlled Initiation with Heparin
Use heparin to prevent procoagulation-mediated thrombosis.
Daily monitoring until a stable therapeutic dose is established.
Regular Monitoring of INR
Regular blood tests (weekly for the first month; monthly thereafter).
Aim for INR 2-3; mechanical heart valves require INR 2.5-3.5.
Patients to call for results within 24 hours and adjust dose if necessary.
Patient Education (Anticoagulant Book)
Dosing
Same brand of tablets.
Same time every day.
Emphasize adherence.
Lifestyle
Dietary Consistency :
Maintain a consistent intake of vitamin K, which is found in green leafy vegetables (e.g., spinach, broccoli, kale).
Avoid sudden changes in the amount of vitamin K in your diet, as this can affect your INR.
Alcohol :
Limit alcohol intake to no more than 1-2 standard drinks per day, as excessive alcohol can increase bleeding risk.
Exercise :
Engage in regular physical activity
avoid contact sports or activities that increase the risk of injury
Side Effects
Heightened awareness of signs of bleeding: headache, abdominal pain, melena, hematuria, nosebleeds.
Pregnancy
Use barrier contraception.
Inform doctor if pregnant.
Interactions
Avoid aspirin.
Inform pharmacist and doctor about any new medications (prescription, herbal, vitamin supplements).
INR tested after 4 days of new drug and at the end of the course.
Inform Healthcare Providers
Inform physiotherapist, podiatrist, chiropractor, dentist.
Surgery
Stop warfarin 4-5 days prior. Substitute with unfractionated or low-molecular-weight heparin subcutaneously.
Medical Alert :
Consider wearing a medical alert bracelet indicating you are on warfarin.
Travel :
If traveling, ensure you have enough medication and arrange for INR testing if you will be away for an extended period.
Complications to Watch Out For
Signs of Bleeding :
Unusual bruising or bleeding (e.g., gums, nosebleeds, heavier menstrual periods).
Dark, tarry stools or blood in your urine.
Severe headaches, dizziness, or weakness (potential signs of internal bleeding).
Prolonged bleeding from cuts or injuries.
Signs of Blood Clots :
Swelling, pain, or tenderness in your legs (potential DVT).
Sudden shortness of breath, chest pain, or coughing up blood (potential PE).
Warfarin Reversal
No Bleeding
INR 5 to 9
Cease warfarin therapy; consider reasons for elevated INR and patient-specific factors.
Vitamin K:
Phytomenadione 1 to 2 mg orally OR
Phytomenadione 0.5 to 1 mg IV
INR 9 or Higher
Low risk of bleeding: cease warfarin therapy and give vitamin K:
Phytomenadione 2.5 to 5 mg orally OR
Phytomenadione 1 mg IV
High risk of bleeding: cease warfarin therapy and give vitamin K:
Prothrombinex -VF 25 to 50 units/kg IV PLUS
Fresh frozen plasma 150 to 300 mL.
Bleeding
Clinically significant bleeding with warfarin-induced coagulopathy:
Phytomenadione 5 to 10 mg IV PLUS
Prothrombinex -VF 25 to 50 units/kg IV PLUS
Fresh frozen plasma 150 to 300 mL (if available).
Related